These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39053454)

  • 1. Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao'an district of Shenzhen,China.
    Wang Z; Chen L; Lu F; Peng J; Huang F; Xie X; Kong D
    Hum Vaccin Immunother; 2024 Dec; 20(1):2364485. PubMed ID: 39053454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on the "Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao'an district of Shenzhen, China".
    Cordero DA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408879. PubMed ID: 39356250
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of the implementation of the two-dose varicella vaccine immunization strategy in Quzhou: A retrospective birth cohort study.
    Wen T; Fang Q; Fu C; Zheng C; Pan J; Zheng B; Xu W; Yin Z
    Hum Vaccin Immunother; 2024 Dec; 20(1):2408847. PubMed ID: 39344170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a two-dose varicella immunization program on the incidence of varicella: a multi-year observational study in Shanghai, China.
    Li Z; Yao Y; Lu X; Liu J; Huang Z; Sun X; Lu Y
    Expert Rev Vaccines; 2021 Sep; 20(9):1177-1183. PubMed ID: 34343035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of sero-epidemiological characteristics of varicella in healthy children in Jiangsu Province, China.
    Zhang L; Ma W; Liu Y; Wang Y; Sun X; Hu Y; Deng X; Lu P; Tang F; Wang Z; Zhou M
    BMC Infect Dis; 2018 Nov; 18(1):563. PubMed ID: 30428851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of protective effect of using chickenpox live attenuated vaccine among 4-17 years old children in Minhang district, Shanghai].
    Du Y; Yu F; Zhang L; Wang X; Jin B; Wang Y; Mei K; Lu J; Jiang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1048-52. PubMed ID: 25619214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella vaccine effectiveness evaluation in Wuxi, China: A retrospective cohort study.
    Xiu S; Xu Z; Wang X; Zhang L; Wang Q; Yang M; Shen Y
    Epidemiol Infect; 2024 Sep; 152():e105. PubMed ID: 39344904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systematic reviews and evidence quality assessment on effectiveness of 1 dose varicella attenuated live vaccine for healthy children aged 1-12 years in China].
    Zhang ZJZ; Suo LD; Zhao D; Pan JB; Lu L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1138-1144. PubMed ID: 32741184
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of two-dose vs. one-dose varicella vaccine in children in Shanghai, China: a prospective cohort study.
    Li Y; Xu F; Liu M; Teng S; Liang F; Wang F
    Front Public Health; 2024; 12():1320407. PubMed ID: 38894987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019.
    Xu Y; Liu Y; Zhang X; Zhang X; Du J; Cai Y; Wang J; Che X; Gu W; Jiang W; Chen J
    Hum Vaccin Immunother; 2021 Jan; 17(1):211-216. PubMed ID: 32574100
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of the varicella vaccine in the real world, a matched case-control study.
    Liu F; Li Z; Wang H; Cao Y; Zhang N; Wang F; Wei R; Zhang J; Zhao Y
    Vaccine; 2024 Jul; 42(19):3968-3973. PubMed ID: 38734496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of varicella in Hangzhou, China in the vaccine era.
    Xu Y; Liu S; Che X; Liu Y; Zhang X; Du J; Zhang X; Wang J; Xu E
    Hum Vaccin Immunother; 2018; 14(10):2464-2471. PubMed ID: 30019992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on epidemiological effect of the freeze-dried attenuated live varicella vaccine].
    Ma FB; Luo LY; Zhang LH
    Zhongguo Yi Miao He Mian Yi; 2009 Jun; 15(3):193-5. PubMed ID: 20084878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel.
    Sheffer R; Segal D; Rahamani S; Dalal I; Linhart Y; Stein M; Shohat T; Somekh E
    Pediatr Infect Dis J; 2005 May; 24(5):434-7. PubMed ID: 15876943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella outbreak trends in school settings during the voluntary single-dose vaccine era from 2006 to 2017 in Shanghai, China.
    Wu QS; Wang X; Liu JY; Chen YF; Zhou Q; Wang Y; Sha JD; Xuan ZL; Zhang LW; Yan L; Hu Y
    Int J Infect Dis; 2019 Dec; 89():72-78. PubMed ID: 31521857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program.
    Quinn HE; Gidding HF; Marshall HS; Booy R; Elliott EJ; Richmond P; Crawford N; McIntyre PB; Macartney KK;
    J Infect; 2019 Mar; 78(3):220-225. PubMed ID: 30528868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program.
    Lopez AS; Kolasa MS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S76-81. PubMed ID: 18419414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.